Research Progress on the Pathogenesis and Treatment of Neoatherosclerosis
This review defines #neoatherosclerosis as a distinct in-stent pathology driven by oxidized lipids and #VSMC foam cells, stressing endothelial injury, #inflammation, and need for strategies beyond #LDL reduction to prevent #restenosis. @2024_HUST #stent
Read: doi.org/10.1007/s115...
Clinical Value of the Quantitative Flow Ratio to Predict Long-term Target Vessel Failure in Patients with In-stent Restenosis after Drug-coated Balloon Angioplasty
Study findings indicate that post-PCI quantitative flow ratio (QFR) is a high-value predictor for long-term target vessel failure in in-stent #Restenosis patients, where a QFR of 0.925 correlates with increased clinical risk.
Read: doi.org/10.1007/s115...
This study shows highlight that the quantitative flow ratio serves as a
predictive marker for long-term target vessel failure in in-#stent #Restenosis patients treated with
DCB, offering new predictive tools in #Cardiology. #medsky
Read here: link.springer.com/article/10.1...
🚀 Ready to master drug-coated balloons? Our first webinar in the #Coronary DCB series is tomorrow! Join us for an expert-led, interactive training on treating in-stent #Restenosis to learn practical skills you can use in the #CathLab.🔑
Register now➡️ scaipro.scai.org/URL/dcb-series
#CardioSky
The PARTHENOPE trial addresses the ongoing challenge of balancing restenosis, stent thrombosis, and bleeding in coronary interventions. Decades of advancements point to the need for personalized strategies in antiplatelet therapy. Read the editorial: ow.ly/JIEX50UIVJ9 #cardiology #restenosis
New laser patterning tech to revolutionise stent surgery for heart diseases yespunjab.com?p=76097
#HeartDisease #StentTechnology #LaserPatterning #VascularRecovery #EndothelialGrowth #Restenosis #MedicalInnovation #KISTResearch #NanosecondLasers #BiodegradableStents
